The open-label, multicenter, randomized Phase 1 trial is designed to evaluate the safety and immunogenicity of experimental HIV trimer mRNA vaccines
Most recently, Rollins was the Chief Information Officer at UnitedHealthcare
Digital meetings driving international partnering at CPhI Japan as companies search for ingredients suppliers
Partners with GITAM University to train 27 employees through a 10-day HR module and make them future-ready
With over 20 years of international leadership experience, Dr. Amrein has led many teams and organizations across over 30 geographies
It will be the first and only global office for traditional medicine in the world
Alongside brand refresh, the leading clinical trial technology company announces eConsent and eCOA offerings to better support the patient clinical trial journey
The breakthrough approval expands the existing indication of Jardiance to include adults with heart failure with preserved ejection fraction (HFpEF), an underserved patient population that previously had no approved therapies in Europe
Earlier today, the Foundation for the National Institutes of Health (FNIH) announced that Dr. Gerberding will become CEO of the FNIH on May 16
Serina has over 17 years of experience in the biopharmaceutical industry
Subscribe To Our Newsletter & Stay Updated
